Gemina Laboratories Ltd. (GLAB.CN)
CAD 0.58
(-8.0%)
CAD 0.58
(-8.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 284.33 Thousand CAD | 80.25% |
| 2022 | 157.74 Thousand CAD | 114.21% |
| 2021 | -1.11 Million CAD | -41.65% |
| 2020 | -783.82 Thousand CAD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | 1.26 Million CAD | 344.78% |
| 2024 Q2 | 980.8 Thousand CAD | -22.45% |
| 2023 Q2 | 206.25 Thousand CAD | 124.8% |
| 2023 Q1 | -831.53 Thousand CAD | -627.13% |
| 2023 Q4 | 284.33 Thousand CAD | -43.18% |
| 2023 FY | 284.33 Thousand CAD | 80.25% |
| 2023 Q3 | 500.39 Thousand CAD | 142.61% |
| 2022 Q4 | 157.74 Thousand CAD | 147.22% |
| 2022 Q3 | -334.07 Thousand CAD | 88.64% |
| 2022 Q2 | -2.94 Million CAD | -978.11% |
| 2022 Q1 | -272.75 Thousand CAD | 75.43% |
| 2022 FY | 157.74 Thousand CAD | 114.21% |
| 2021 Q1 | -2.08 Million CAD | -147.25% |
| 2021 FY | -1.11 Million CAD | -41.65% |
| 2021 Q3 | -2.14 Million CAD | -57.41% |
| 2021 Q2 | -1.36 Million CAD | 34.63% |
| 2021 Q4 | -1.11 Million CAD | 48.31% |
| 2020 Q4 | -844.34 Thousand CAD | 0.0% |
| 2020 FY | -783.82 Thousand CAD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Algernon Pharmaceuticals Inc. | -125.08 Thousand CAD | 327.314% |
| Asep Medical Holdings Inc | -44.72 Thousand CAD | 735.8% |
| BetterLife Pharma Inc. | 207.85 Thousand CAD | -36.799% |
| BioVaxys Technology Corp. | -977.00 CAD | 29202.968% |
| ChitogenX Inc. | 3.84 Million CAD | 92.595% |
| Rapid Dose Therapeutics Corp. | 2.29 Million CAD | 87.598% |
| Defence Therapeutics Inc. | 1.68 Million CAD | 83.174% |
| Entheon Biomedical Corp. | -344.63 Thousand CAD | 182.504% |
| Glow Lifetech Corp. | 116.15 Thousand CAD | -144.801% |
| Lexston Life Sciences Corp. | -390.4 Thousand CAD | 172.831% |
| Pharmala Biotech Holdings Inc. | 58.49 Thousand CAD | -386.086% |
| Doseology Sciences Inc. | -1.06 Million CAD | 126.819% |
| MYND Life Sciences Inc. | 2.99 Million CAD | 90.521% |
| Nova Mentis Life Science Corp. | -8088.00 CAD | 3615.529% |
| PharmaTher Holdings Ltd. | -2.13 Million CAD | 113.329% |
| PreveCeutical Medical Inc. | 3.83 Million CAD | 92.581% |
| Telescope Innovations Corp. | -719.49 Thousand CAD | 139.519% |